Internal Medicine · Fresno, CA
NPI
1417906835
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
7065 N. Maple Ave, Ste 102
Fresno, CA, 93720
Phone (559) 554-2100
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
66,943 services
Medicare patients, 2024
480
Average age 75
Drug cost, 2024
$3.0M
1,345 prescriptions
Company payments, 2025
$8,619
From 49 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad M Alam was code J1642 (injection, heparin sodium, (heparin lock flush), per 10 units), 3,860 times for 20 patients. In total Muhammad M Alam billed 66,943 services in 117 codes, and Medicare paid $1.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-12.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 3,860 | 20 | $0.01 | $51.71 |
| J0897 Injection, denosumab, 1 mg | Office | 3,480 | 16 | $21.09 | $73K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 3,200 | 28 | $15.83 | $51K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 916 | 14 | $0.09 | $81.18 |
| J3490 Unclassified drugs | Office | 594 | 13 | $0.02 | $13.7 |
| 99214 Office E&M - Established | Office | 572 | 249 | $97.12 | $56K |
| 99233 Hospital E&M - Subsequent | Facility | 437 | 91 | $93.83 | $41K |
| 96372 Injection Administration | Office | 358 | 81 | $11.45 | $4,101 |
| 96361 Intravenous Infusion, Hydration | Office | 280 | 45 | $10.42 | $2,918 |
| 99215 Office E&M - Established | Office | 276 | 123 | $138.62 | $38K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 158 | 40 | $0.97 | $153 |
| 96367 Intravenous Infusion, Hydration | Office | 126 | 17 | $24.23 | $3,053 |
| 99223 Hospital E&M - Initial | Facility | 117 | 101 | $137.45 | $16K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 106 | 40 | $0.51 | $54.43 |
| 99232 Hospital E&M - Subsequent | Facility | 102 | 46 | $63.11 | $6,437 |
By year: 2022 $231K for 2,836 services; 2023 $204K for 2,704 services; 2024 $1.1M for 66,943 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 55 | 11 | $7.61 | $419 |
| 80053 Clinical Chemistry | 37 | 11 | $10.35 | $383 |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad M Alam prescribed most often to Medicare patients was Eliquis (Apixaban), with 94 prescriptions and refills. In total Muhammad M Alam wrote 1,345 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 94 | 120 | 23 | $63K |
| Dexamethasone Generic | 75 | 89 | 36 | $1,323 |
| Anastrozole Generic | 65 | 157 | 30 | $1,599 |
| Ondansetron Odt Ondansetron | 64 | 66 | 43 | $2,104 |
| Clinisol Parenteral Amino Acid 15% No.5 | 55 | 55 | Under 11 | $19K |
| Gabapentin Generic | 37 | 42 | 11 | $327 |
| Prochlorperazine Maleate Generic | 34 | 34 | 26 | $471 |
| Prednisone Generic | 33 | 52 | 18 | $281 |
| Hydroxyurea Generic | 33 | 79 | 12 | $588 |
| Pantoprazole Sodium Generic | 32 | 60 | 13 | $432 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 31 | 31 | 16 | $1,019 |
| Levothyroxine Sodium Generic | 27 | 60 | Under 11 | $260 |
| Potassium Chloride Generic | 26 | 41 | 11 | $659 |
| Acyclovir Generic | 26 | 34 | Under 11 | $817 |
| Xarelto Rivaroxaban | 26 | 36 | Under 11 | $19K |
Brand drugs: 336 claims; generic drugs: 1,009 claims; opioid claims: 70.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad M Alam $8,619 ($8,619 in general payments such as food, travel and fees) from 49 companies. The largest payer was Abbvie Inc. with $3,650.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $3,650 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $1,014 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $330 |
| Pfizer Inc. PFE | 7 | $247 |
| Janssen Biotech, Inc. JNJ | 10 | $210 |
| Sobi, Inc SOBI.ST | 9 | $199 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $192 |
| Astellas Pharma US Inc 4503.T | 10 | $175 |
| GlaxoSmithKline, LLC. GSK | 11 | $167 |
| Daiichi Sankyo Inc. 4568.T | 14 | $163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.